登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600713 证券简称：南京医药 编号：ls2026-015 债券代码：110098 债券简称：南药转债 南京医药集团股份有限公司 2024年度第一期中期票据 2026年付息公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 为保证南京医药集团股份有限公司（以下简称"公司"）2024年度第一期中期票据（债券简称：24南京医 药MTN001，债券代码：102480759.IB）付息工作的顺利进行，现将有关事宜公告如下： 一、本期债券基本情况 ■ 二、兑付相关事宜 托管在银行间市场清算所股份有限公司的债券，其付息资金由发行人在规定时间之前划付至银行间市场 清算所股份有限公司指定的收款账户后，由银行间市场清算所股份有限公司在付息日划付至债券持有人 指定的银行账户。债券付息日如遇法定节假日，则划付资金的时间相应顺延。债券持有人资金汇划路径 变更，应在付息前将新的资金汇划路径及时通知银行间市场清算所股份有限公司。因债券持有人资金汇 划路径变更未及时通知银行间市场清算所股份有限 ...

Core Points - The company plans to apply for registration and issuance of short-term financing bonds not exceeding RMB 2 billion [1] - The fifth phase of the short-term financing bonds for 2025 has been successfully issued with a total issuance amount of RMB 400 million [1] - The issuance interest rate for the bonds is set at 1.68% [1] Summary by Sections Company Announcement - The company guarantees that the information disclosed is true, accurate, and complete without any false records or misleading statements [1] - The company is not listed as a dishonest entity according to the "Credit China" website [2] Financing Details - The fifth phase of the 2025 short-term financing bonds has a term of 61 days, with an interest start date on October 8, 2025, and a maturity date on October 22, 2025 [1] - The bonds were issued at a price of 100.00 yuan per 100 yuan [1] - The lead underwriter for the issuance is Industrial Bank Co., Ltd., with Hengfeng Bank Co., Ltd. as a co-lead underwriter [1]